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Abstract
In this essay, we first take a critical look at the definitions of evidence-based 
medicine (EBM) and complementary and alternative medicine (CAM). We then 
explore the question of whether there can be evidence-based forms of CAM. 
With the help of three examples, we show that EBM and CAM are not opposites, 
but rather concepts pointing at different dimensions. Each of the three examples 
is an evidence-based treatment according to three to five randomized, double-
blind placebo controlled trials with consistent findings and narrow pooled 
confidence intervals. The most reasonable interpretation for the existence of 
evidence-based CAM treatments seems to be that the opposite of CAM is 
‘mainstream medicine’, and the demarcation line between CAM and mainstream 
medicine is not defined by the question of whether a treatment works or not. 
Some effective treatments may belong to the CAM field for historical reasons 
and because of preconceptions within mainstream medicine. Therefore, some 
treatments that currently lie outside mainstream medicine can be evidence-based.
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In 2004, the journal Evidence-Based Complementary and Alternative Medicine (eCAM) was 
launched. According to its website, it ‘seeks to understand the sources and to encourage rigorous 
research in this new, yet ancient world of complementary and alternative medicine.’1 
eCAM is an open access journal that published over 1000 papers in 2013.
This new combination of ‘evidence-based medicine’ (EBM) and ‘complementary and alternative 
medicine’ (CAM) is interesting, but we find it strange that the journal does not provide any 
definition or explanation of the two terms. Both terms have many meanings, and their combination 
can also be understood in numerous ways. 
The aim of this essay is to look at the definitions of EBM and CAM and then explore the question 
of whether there can be evidence-based forms of CAM.  
What is EBM? 
The term evidence-based medicine (EBM) appeared initially in an information document aimed 
at prospective or new students at the McMaster University in Canada in the autumn of 1990.2 
McMaster was the home of a group of physicians who demanded that clinical decisions be based 
on ‘best evidence’. 
The concept EBM was introduced to the wide medical community in JAMA in 1992.3 EBM was 
promoted as ‘a new approach to teaching the practice of medicine’ and a ‘new paradigm of medical 
practice’. No specific definition was given in the article, but according to it EBM ‘de-emphasizes 
intuition, unsystematic clinical experience, and pathophysiologic rationale as sufficient grounds 
for clinical decision-making and stresses the evidence from clinical research’. In particular, 
the 1992 paper instructed clinicians to search for studies with the question ‘Was the assignment 
of patients to treatments randomized?’ The article was a bold programme statement that divided the 
medical world into the old-fashioned pre-EBM and the revolutionary new EBM types of medicine. 
A rather general definition of EBM was formulated four years later: 
Evidence-based medicine is the conscientious, explicit, and judicious use of current 
best evidence in making decisions about the care of individual patients.4 
This has remained the most widely cited definition of EBM. Nevertheless, it is not a surprise that 
the medical world did not unanimously welcome this new programme. A few years later, Charlton 
and Miles published a paper titled ‘The Rise and Fall of EBM’, in which they sharply criticised 
the EBM approach.5 Another critic, Mark Tonelli, noted that there is certainly not a physician alive 
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who would not claim to practise EBM when it is defined as the ‘conscientious, explicit and 
judicious use of current best evidence in making decisions’.6 The above a definition of EBM 
is so vague that it does not provide any demarcation line between EBM and non-EBM. 
Later, other definitions of EBM have been proposed such as: 
 EBM is currently understood to incorporate clinical epidemiological data, 
meaningful deliberations of professionals’ pathophysiological knowledge 
and clinical experience, together with patient preferences.7 
…the evidence to which EBM refers to ought to comprise six dimensions: 
scientific evidence, theoretic evidence, practical evidence, expert evidence, 
judicial evidence and ethics-based evidence.8 
These definitions demonstrate the multitude of meanings that term EBM has nowadays. 
They also raise the question of whether there is any actual difference between EBM and pre-EBM, 
since all six dimensions were important issues in mainstream medicine also before 1992. 
In 2005 Timmermans and Mauck wrote sarcastically that
The term [EBM] is loosely used and can refer to anything from conducting 
a statistical meta-analysis of accumulated research, to promoting randomized 
clinical trials, to supporting uniform reporting styles for research, 
to a personal orientation toward critical self-evaluation.9 
Despite the disagreements and confusions about the basic definitions, one aspect in the EBM 
programme has been particularly essential since the introduction of the term in JAMA in 1992, 
namely, the view of valid evidence: ‘comparative clinical studies, preferably from randomized 
trials [RCTs], are deemed to provide better evidence than mechanistic reasoning and clinical 
experience.’2,3 [our italics]
What is CAM? 
CAM is an acronym combining two terms, ‘complementary medicine’ and ‘alternative medicine’, 
neither of which is ancient. According to PubMed, ‘alternative medicine’ first appeared in medical 
journals in 1975 and ‘complementary medicine’ in 1985.10 
The former term dates back to the alternative lifestyle movement that originated in the United States
in the late 1960s.10,11 The latter term was adopted in Britain with the political objective of raising the
question of whether medicine could include some of the alternative healing practices in its tool kit.10
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A further related term, ‘integrative medicine’, was introduced in the 1990s in order to suggest 
a deeper marriage between alternative treatments and medicine.10 
The meanings of ‘alternative’ in ‘alternative medicine’ or ‘complementary’ in ‘complementary 
medicine’ have not been properly explained, and it is common that their supporters present 
‘official’ medicine as a rigid and closed system that is full of prejudices. ‘Alternative’ and 
‘complementary’ are often used as buzzwords, important-sounding phrases ‘of little meaning 
used chiefly to impress laymen’.12 The proponents of CAM often use other buzzwords like 
‘natural’ or ‘holistic’, the meanings of which are vague.11,13 
Wolpe has suggested that CAM is best understood as a ‘residual category’, which means that 
it is defined by its exclusion from ‘official’ or ‘medical school’ medicine, which we call 
‘mainstream medicine’ in this essay.14 
The Committee on the Use of Complementary and Alternative Medicine of the American Public 
Board on Health Promotion and Disease Prevention defined CAM as
… a broad domain of resources that encompasses health systems, modalities, and 
practices and their accompanying theories and beliefs, other than those intrinsic 
to the dominant health system of a particular society or culture in a given historical 
period. CAM includes such resources perceived by their users as associated with 
positive health outcomes. Boundaries within CAM and between the CAM domain 
and the domain of the dominant system are not always sharp or fixed.15 
Like the definitions of EBM, the preceding definition is too vague to provide even a rough 
demarcation line between CAM and the ‘dominant system’. It is, however, an important description
in pointing out the diversity of the phenomena behind the concept. This complexity also explains 
why the boundaries between the CAM domain and mainstream medicine are not sharp or constant. 
The meanings of CAM and ‘alternative medicine’ largely overlap, and, for the purposes of this 
essay, we use the short and pragmatic definition of the latter that was used in 1998 in a study 
on national trends on the use of alternative medicine in the United States: 
Alternative medical therapies, functionally defined as interventions 
neither taught widely in medical schools nor generally available in US hospitals... 16
Although such a sociological definition has its own problems, we consider it to be the most useful 
definition for the purpose of our essay.
4
Are there EBM treatments in the CAM field?
Thus EBM and CAM are both rather vague terms that escape rigorous definitions. Here we take 
a pragmatic approach and consider CAM to mean therapies that lie outside mainstream medicine. 
We also consider the most fundamental principle of EBM to be the requirement that treatments 
are based on RCTs. Thus various treatments can be arranged simultaneously into a 2 × 2 table 
on the basis of both concepts as shown in Table 1.





(treatments based on RCTs)
1 3
Not EBM 
(treatments not based on RCTs)
2 4
Cell 1 in Table 1 covers treatments in mainstream medicine that are based on numerous 
large RCTs (e.g., treatments of hypertension and myocardial infarction). 
Cell 2 covers mainstream medicine treatments that are not based on RCTs. It not only includes 
potentially ineffective treatments that are used for historical reasons, but also treatments that 
cannot be examined with RCTs because of practical or ethical reasons (e.g. antibiotics for severe 
bacterial infections, volume replacement therapy in severe bleeding). Such treatments are justified 
on the basis of ‘mechanistic reasoning and clinical experience’, which are discouraged by 
the proponents of EBM.3 Thus Cell 2 is a mixed collection of valid treatments (though not based 
on RCTs) and potentially ineffective treatments.
For this essay, the most interesting part of Table 1 is Cell 3. Are there treatments that are based 
on RCTs but lie outside mainstream medicine? If we argue that a treatment falls into Cell 3, 
we must first prove that the treatment belongs to the CAM field, and, second, there must be 
consistently positive findings in RCTs that justify the conclusion that the treatment is effective.
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Vitamins and minerals are commonly classified as a form of CAM. For example, the National 
Center for Complementary and Alternative Medicine (NCCAM), which is part of the National 
Institutes of Health in the United States, states on its website that ‘Natural [CAM] Products’ include
‘vitamins and minerals ... They are widely marketed, readily available to consumers, and often sold 
as dietary supplements.’17 Specifically, according to the NCCAM, vitamin C and zinc for the 
common cold falls into the CAM category18, as does vitamin C for asthma.19 The Cochrane Library 
also classifies these three treatments as CAM treatments.20 We suggest that there is strong evidence 
for the efficacy of these three treatments. In our view, they are examples of treatments that fall 
into Cell 3 in Table 1. 
In three RCTs, high-dose zinc acetate lozenges shortened the duration of colds by 42% (95% CI: 
35% to 48%).21 In five RCTs vitamin C administration reduced the incidence of cold symptoms 
in people under short-term physical stress by 48% (95% CI: 35% to 64%).22 Finally, in three RCTs, 
vitamin C administration was beneficial for patients with exercise-induced asthma since it reduced 
the post-exercise decline in forced expiratory flow in 1 second (FEV1) by 48% (95% CI: 33% 
to 64%).23 Thus, according to the NCCAM and the Cochrane Library, these treatments fall into 
the CAM field, and, on the basis of consistent positive RCT findings, they are EBM treatments.
Why are the three preceding examples part of CAM 
and not part of current mainstream medicine?
In the preceding discussion, we showed that EBM and CAM are not opposites, but rather they are 
concepts pointing at different dimensions (Table 1). In our view, the opposite of CAM is 
‘mainstream medicine’, which is not the same as EBM. For example, ‘mechanistic reasoning’, 
i.e. theoretical argumentation, has been an essential part of mainstream medicine for two millennia, 
and, in many time periods, theory has been much more important than empiricism.24-26 However, 
mechanistic reasoning is explicitly de-emphasized by EBM, which strongly favours RCTs.2,3
EBM originated from the concern that numerous ineffective treatments had been adopted by 
mainstream medicine, and the RCT was viewed as the most reliable method with which to identify 
the treatments that actually work. However, there is an opposite problem ‘when an efficacious 
treatment for a certain disease is ignored or rejected because it does not make sense in the light 
of accepted theories of disease mechanism and drug action’.24 Goodwin and Goodwin (1984) named
this phenomenon ‘the tomato effect’. With this name, they were referring to the historical 
background of the United States, where tomatoes were considered poisonous for a few centuries 
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after they had been widely adopted in European kitchens. The idea of tomatoes being poisonous 
was based on theoretical argumentation: the tomato belongs to the Solanaceae family, which 
includes several deadly poisonous plants; therefore tomatoes must also be poisonous.24 
Goodwin and Goodwin24,25 gave several examples of medical ‘tomatoes’: treatments that were 
rejected because they did not fit prevailing theories. Furthermore, in some cases, the effective 
treatment had been used for a long time, but changes in the theories of pathogenesis led to the 
rejection of the treatments because they no longer made any sense, even though the clinical effects 
did not disappear with the changes in theories.
With the recent explosion in the molecular level understanding of the origin of diseases, 
the importance of theoretical explanations has not been decreasing in mainstream medicine. 
However, if the emphasis on theory is too strong, the evaluation of treatments focuses on 
theoretical explanations, and not on the empirical question of whether a treatment works or not.24-26
In mainstream medicine, the dominant theory of vitamins is that their purpose in the body 
is to prevent deficiency diseases, and thereby their other use belongs to the CAM field.17,26 
Nevertheless, there are biological rationalisations to explain some effects of vitamins unrelated 
to treating deficiencies. For example, exercise causes oxidative stress, and vitamin C, 
as an antioxidant, could protect against such stress. Consequently, the effects of vitamin C may be 
particularly pronounced during exercise, which is the factor common in two of the aforementioned 
effects.22,23 However, such an explanation is rather vague when compared with the explanations 
of the effects of modern drugs that bind to well-defined specific receptors.
In addition to the emphasis on theories, Goodwin and Goodwin mentioned another reason for 
the ‘tomatoes’ in medicine: ‘if a treatment bypasses the medical establishment and is sold directly 
to the public … the temptation in the medical community is to accept uncritically the first bad 
news that comes along’.24,26 This seems to be a problem also with the three examples given in 
the preceding discussion.
Two influential reviews on vitamin C and the common cold in the 1970s concluded that vitamin C 
is useless for colds, and the reviews were extensively cited. However, the reviews were shown 
to be flawed over a decade ago.27,28 Apparently the conclusions of the reviews fitted so well with 
the theory in mainstream medicine that the validity of the reviews was not considered when they 
were published. Cochrane reviews are usually restricted to RCTs, which does not imply that they 
are always trustworthy. Those on zinc and the common cold, and on vitamin C and asthma, 
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were shown to have severe errors in the extraction of data and in the data analysis, and these errors 
invalidate the conclusions of the reviews.29-31 
CAM covers diverse treatments that have little in common, 
except for being outside mainstream medicine 
There is no unifying theory behind all of the diverse CAM treatments. We agree with Wolpe14 
(see the preceding discussion), according to whom CAM is best understood as a ‘residual category’,
in other words, a category of treatments outside mainstream medicine. In our view, many or most 
CAM treatments are not credible from the scientific point of view. Nevertheless, as shown 
in the preceding discussion, the fact that a specific treatment falls into the CAM field does 
not prove that it is ineffective. 
Some CAM treatments, such as homeopathy, are fundamentally incompatible with science. 
We do not believe that such treatments will ever become part of mainstream medicine, even if 
some RCT findings have been positive. Publication bias and methodological flaws are far more 
plausible explanations for the positive RTC results related to homeopathy than errors in basic 
theories of chemistry are. When there is a very strong theory, empiricism is secondary. This 
statement not only applies to the rejection of homeopathy, but also, for example, to the use 
of antibiotics for severe infections irrespective of whether RCTs have been carried out or not. 
Some treatments, such as the three aforementioned examples, may belong to the CAM field 
for historical reasons and preconceptions within mainstream medicine. We assume that, 
sooner or later, such treatments will be included in mainstream medicine instead of CAM. 
As noted in the beginning of this essay, the journal Evidence-Based Complementary and 
Alternative Medicine (eCAM) has announced that it ‘seeks to understand the sources and 
to encourage rigorous research in this new, yet ancient world of complementary and alternative 
medicine’.1 To explore the meaning of the term ‘evidence-based’ in the journal, we reviewed 
100 consecutive papers that were published in eCAM in Autumn 2013. We found out that only 
10% of them reported the results of RCTs and about 50% reported the results of animal or in vitro 
experiments. In this respect the term ‘evidence-based’ seems to be more of a marketing term 
to increase the credibility of the journal1 than a signal of adherence to EBM reasoning.
8
Conclusions
The purpose of our essay is not to provide general support to CAM treatments. Instead, 
the purpose is to point out that the demarcation line between CAM and mainstream medicine 
is not simply defined by the question of whether a treatment works or not. The demarcation line 
is also defined by historical and political grounds, and by the theories of disease aetiologies 
and treatment mechanisms. Mainstream medicine does not equal EBM, which emphasizes 
RCTs as the source of valid information on treatment efficacy. Consequently, some treatments 
that currently lie outside mainstream medicine can therefore be evidence-based. 
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